Clinical trials
Dyslipidemias trials in Chile
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 11 |
| Pontificia Universidad Catolica de Chile | 2 |
| 89bio, Inc. | 1 |
| Amgen | 1 |
| GlaxoSmithKline | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Regeneron Pharmaceuticals | 1 |
| Universidad Católica San Antonio de Murcia | 1 |
| University of Chile | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 21 |
| Diabetes Mellitus, Type 2 | 12 |
| Diabetes Mellitus | 10 |
| Glucose Metabolism Disorders | 10 |
| Diabetes Mellitus, Lipoatrophic | 5 |
| Hypercholesterolemia | 5 |
| Hyperlipidemias | 4 |
| Atherosclerosis | 2 |
| Hypertension | 2 |
| Lipid Metabolism Disorders | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.